NCT00441116View on ClinicalTrials.gov

A Study To Assess The Efficacy And Safety Of Dutasteride 0.5mg Once Daily For 6 Months In The Treatment Of Male Subjects With Androgenetic Alopecia

PHASE3CompletedINTERVENTIONAL

Enrollment

153

Participants

Timeline

Start Date

December 15, 2006

Primary Completion Date

January 21, 2008

Study Completion Date

January 21, 2008

Conditions

Alopecia

Interventions

DRUG

Dutasteride 0.5mg oral tablets

Dutasteride

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY